AKKARAJU SRINIVAS 4
4 · ALUMIS INC. · Filed Jul 2, 2026
Research Summary
AI-generated summary of this filing
ALUMIS (ALMS) Director Srinivas Akkaraju Receives Share Awards
What Happened Srinivas Akkaraju, a director of ALUMIS, was granted two awards on 2026-06-30: 3,553 shares (RSUs) and 15,528 derivative shares, each recorded at $0.00 per share (total reported value $0). The RSU award is subject to vesting; the second line reflects a derivative award/holding related to entities tied to the Reporting Person.
Key Details
- Transaction date: 2026-06-30; Form 4 filed 2026-07-02 (appears timely for the 2-business-day Form 4 window).
- Prices: $0.00 per share for both line items; total reported cash consideration = $0.
- Vesting for the 3,553 RSUs: vest on first anniversary of grant, or fully vest by the Issuer's 2027 annual meeting, subject to continuous service; vest in full upon a Change in Control (per footnote).
- The 15,528 "derivative" shares are associated with entities (Samsara BioCapital LP and Samsara Opportunity Fund) described in the filing; the Reporting Person is a managing member/has voting & investment power but disclaims beneficial ownership except to the extent of his pecuniary interest.
- Shares owned after the transaction are not specified in the excerpt provided — see the full Form 4 for total beneficial ownership counts and holdings breakdown.
Context
- The 3,553-item is an RSU award (restricted stock unit) that converts to common shares when vested; this is a compensation award rather than an open-market purchase or sale. RSU vesting terms (time-based and change-in-control) are noted on the filing.
- The 15,528 entry involves securities held by investment vehicles connected to the Reporting Person; such entries often reflect holdings controlled through funds and include disclaimers of direct beneficial ownership.
- Awards like these are routine forms of executive/director compensation and do not, by themselves, indicate the insider is buying or selling stock for immediate market exposure. Check the full Form 4 for ownership totals and any additional footnotes.
Insider Transaction Report
Form 4
ALUMIS INC.ALMS
AKKARAJU SRINIVAS
Director
Transactions
- Award
Common Stock
[F1]2026-06-30+3,553→ 3,553 total - Award
Stock Option (Right to Buy)
[F4]2026-06-30+15,528→ 15,528 totalExercise: $28.14Exp: 2036-06-29→ Common Stock (15,528 underlying)
Holdings
- 4,491,731(indirect: By Samsara BioCapital, L.P.)
Common Stock
[F2] - 1,853,488(indirect: By Samsara Opportunity Fund, L.P.)
Common Stock
[F3]
Footnotes (4)
- [F1]Represents shares of common stock issuable upon settlement of a restricted stock unit ("RSU") grant. The shares underlying this RSU vest on the first anniversary of the date of grant, provided that the shares will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2024 Equity Incentive Plan (the "Plan")) through such vesting date and will vest in full upon a Change in Control (as defined in the Plan), subject to the Reporting Person's Continuous Service (as defined in the Plan) through such date.
- [F2]Shares are directly held by Samsara BioCapital LP. ("Samsara LP"). The Reporting Person is a managing member of Samsara BioCapital GP, LLC, the general partner of Samsara LP. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- [F3]Shares are directly held by Samsara Opportunity Fund, L.P. ("Samsara Opportunity Fund"). Samsara Opportunity Fund GP, LLC is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the shares held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the shares held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein.
- [F4]The shares underlying this option vest on the first anniversary of the date of grant, provided that the shares will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting, subject to the Reporting Person's Continuous Service (as defined in the Plan) through such vesting date and will vest in full upon a Change in Control (as defined in the Plan), subject to the Reporting Person's Continuous Service (as defined in the Plan) through such date.
Signature
/s/ Sanam Pangali, Attorney-in-Fact|2026-07-02